Edition:
United States

Hans Biomed Corp (042520.KQ)

042520.KQ on KOSDAQ - Korea Secs Dealers Association Quotation

17,200.00KRW
26 Apr 2017
Change (% chg)

₩200.00 (+1.18%)
Prev Close
₩17,000.00
Open
₩17,150.00
Day's High
₩17,250.00
Day's Low
₩16,800.00
Volume
32,037
Avg. Vol
28,457
52-wk High
₩23,500.00
52-wk Low
₩13,250.00

Latest Key Developments (Source: Significant Developments)

Hans Biomed sees FY 2017 revenue to be 37 bln won
Wednesday, 22 Feb 2017 02:30am EST 

Hans Biomed Corp <042520.KQ> :Sees FY 2017 revenue to be 37 billion won.  Full Article

Hans Biomed signs license agreement with 2A2M Enterprise S.A.S
Monday, 29 Aug 2016 03:37am EDT 

Hans Biomed Corp <042520.KQ> : Says it signs license agreement with 2A2M Enterprise S.A.S, for a right to sell BellaGel in Mexico .Contract price of 2.97 billion won.  Full Article

Hans Biomed signs contract
Thursday, 2 Jun 2016 10:59pm EDT 

Hans Biomed <042520.KQ> Co.,Ltd: Says it signed contract with Shanghai-based co, to supply silicone polymer .Contract amount of 11.54 billion won.  Full Article

HANS BIOMED signs contract with BNS Med
Monday, 7 Dec 2015 07:48pm EST 

HANS BIOMED CORP:Signs contract with BNS Med, to supply BellaGel.Contract amount of 13,041 mln won.  Full Article

HANS BIOMED declares annual cash dividend for 2015
Monday, 16 Nov 2015 12:59am EST 

HANS BIOMED CORP:To pay cash dividend of 100 won per share to shareholders of record on Sep. 30, for 2015.Payment date is Jan. 29, 2016.Total dividend amount of 941,737,300 won.  Full Article

HANS BIOMED amends transaction settlement date of establish new subsidiary in China
Monday, 2 Nov 2015 01:28am EST 

HANS BIOMED CORP:Amends transaction settlement date of establish a new wholly owned subsidiary in China, to Dec. 31 from Oct. 30.  Full Article

HANS BIOMED amends amount of contract with China-based company
Wednesday, 30 Sep 2015 01:13am EDT 

HANS BIOMED CORP:The amount of a contract with a China-based company to supply facial silicone implants, was amended to 3,033,407,395 won from 2,421,132,000 won.  Full Article

HANS BIOMED to establish new subsidiary in China
Wednesday, 23 Sep 2015 01:38am EDT 

HANS BIOMED CORP:To invest 412,020,000 won to set up a wholly owned subsidiary namely Shanghai Hansbiomed Corp. in China.The new entity will be engaged in the manufacturing and sale of biotechnology related products.The new entity will be capitalized at 412,020,000 won.Expected transaction settlement date of Oct. 30.  Full Article

More From Around the Web

BRIEF-Hans Biomed to pay interim dividend as 100 won per share

* Says it will pay interim dividend to shareholders recorded on Sep. 30, as 100 won per share